Avestar Capital’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$940K Buy
11,235
+3,280
+41% +$247K 0.06% 235
2025
Q4
$533K Sell
7,955
-5,223
-40% -$338K 0.03% 327
2025
Q3
$891K Buy
13,178
+3,271
+33% +$237K 0.06% 242
2025
Q2
$738K Sell
9,907
-957
-9% -$63.7K 0.05% 264
2025
Q1
$684K Buy
10,864
+7,009
+182% +$433K 0.06% 251
2024
Q4
$220K Buy
+3,855
New +$228K 0.02% 462
2019
Q3
Sell
-582
Closed -$14K 322
2019
Q2
$14K Buy
+582
New +$15.7K 0.01% 447

Other funds holding CTVA

Avestar Capital's CTVA Position: Q1 2026 in Review

Avestar Capital increased its Corteva (CTVA) stake by 41% in Q1 2026, buying an estimated $247K and bringing the position to 11,235 shares worth $940K. The position accounts for 0.06% of the portfolio, ranked #235.

Avestar Capital first reported a position in CTVA in Q2 2019 and has held it in 7 quarters since. 1,476 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

  • Avestar Capital held 11,235 shares of Corteva worth $940K as of Q1 2026.
  • Avestar Capital bought 3,280 Corteva shares in Q1 2026, an estimated $247K.
  • Corteva made up 0.06% of Avestar Capital's portfolio in Q1 2026, its #235 holding.
  • Avestar Capital first reported a position in Corteva in Q2 2019 and has held it in 7 quarters since.
  • 1,476 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on Avestar Capital's 13F filing for Q1 2026, filed 13 May 2026.